MedPath

Effect of Juzentaihoto on total hip arthroplasty: randomized controlled trial

Not Applicable
Recruiting
Conditions
total hip arthroplasty
Registration Number
JPRN-UMIN000038213
Lead Sponsor
Showa University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
120
Inclusion Criteria

Not provided

Exclusion Criteria

Patients allergic to Juzentaihoto

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Alb change rate 4 weeks before surgery and 1, 3, 5, 7, 14 days after surgery
Secondary Outcome Measures
NameTimeMethod
Hb value, infection rate, ADL improvement rate, length of hospital stay, home discharge rate, CRP value, NRS, JOA score, walking ability
© Copyright 2025. All Rights Reserved by MedPath